This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07535/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB07535/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07535/identifier/pubchem-compound/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07535/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07535/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07535
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB07535 n14:DB07535
dcterms:title
2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one
adms:identifier
n6:C8C n7:99444006 n8:11651760 n9:9826498 n10:DB07535
n3:IUPAC-Name
n4:271B4DDE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4DE4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4DE3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4DE0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4DE1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4DE2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4DDC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4DDA-363D-11E5-9242-09173F13E4C5 n4:271B4DDD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4DDB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4DEA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4DEB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4DE5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4DE6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4DE8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4DE7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4DE9-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4DF0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4DF2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4DF3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4DEF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4DEE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4DF1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4DDF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4DEC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4DED-363D-11E5-9242-09173F13E4C5